We are live on ! Find out more
SGH

Sivik Global Healthcare Portfolio holdings

AUM $132M
1-Year Est. Return 24.1%
This Fund
S&P 500
This Quarter Est. Return
+12.89%
1 Year Est. Return
+24.1%
3 Year Est. Return
+53.78%
5 Year Est. Return
+97.1%
10 Year Est. Return
+690.63%
AUM
$245M
AUM Growth
+$12.8M
Cap. Flow
-$9.76M
Cap. Flow %
-3.98%
Top 10 Hldgs %
37.52%
Holding
47
New
9
Increased
11
Reduced
14
Closed
9

Top Buys

Rank Stock Value
1
ELV icon
Elevance Health
ELV
+$6.14M
2
THC icon
Tenet Healthcare
THC
+$5.49M
3
REGN icon
Regeneron Pharmaceuticals
REGN
+$5.4M
4
INCY icon
Incyte
INCY
+$5.19M
5
CAH icon
Cardinal Health
CAH
+$5.19M

Top Sells

Rank Stock Value
1
PPD
PPD, Inc. Common Stock
PPD
+$7.4M
2
COR icon
Cencora
COR
+$5.82M
3
DGX icon
Quest Diagnostics
DGX
+$5.72M
4
MRK icon
Merck
MRK
+$4.98M
5
LHCG
LHC Group LLC
LHCG
+$3.72M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
2 Energy 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CTLT
26
DELISTED
CATALENT, INC.
CTLT
$5.72M 2.33%
55,000
-37,500
-41% -$3.63M
CAH icon
27
Cardinal Health
CAH
$54.5B
$5.36M 2.18%
+100,000
New +$5.19M
INCY icon
28
Incyte
INCY
$24.5B
$5.22M 2.13%
+60,000
New +$5.19M
CRL icon
29
Charles River Laboratories
CRL
$13.6B
$5M 2.04%
20,000
-5,000
-20% -$1.19M
BIO icon
30
Bio-Rad Laboratories Class A
BIO
$9.68B
$4.66M 1.9%
8,000
+500
+7% +$285K
GRFS
31
Grifois
GRFS
$5.4B
$4.61M 1.88%
+250,000
New +$4.63M
ELAN icon
32
Elanco Animal Health
ELAN
$11.1B
$4.6M 1.88%
+150,000
New +$4.58M
CNC icon
33
Centene
CNC
$33.1B
$4.5M 1.84%
75,000
-50,000
-40% -$3.18M
EHC icon
34
Encompass Health
EHC
$12.3B
$3.72M 1.52%
56,565
-25,140
-31% -$1.48M
RGEN icon
35
Repligen
RGEN
$9.35B
$2.87M 1.17%
+15,000
New +$2.73M
ACH
36
Accendra Health
ACH
$93.1M
$2.71M 1.1%
100,000
-25,000
-20% -$643K
NTRA icon
37
Natera
NTRA
$45.5B
$1.99M 0.81%
+20,000
New +$1.67M
ADPT icon
38
Adaptive Biotechnologies
ADPT
$4.02B
$1.18M 0.48%
+20,000
New +$1.03M
AMED
39
DELISTED
Amedisys
AMED
– –
-15,000
Closed -$3.55M
BIIB icon
40
Biogen
BIIB
$30.9B
– –
-12,000
Closed -$3.4M
COR icon
41
Cencora
COR
$60B
– –
-60,000
Closed -$5.82M
DGX icon
42
Quest Diagnostics
DGX
$26.2B
– –
-50,000
Closed -$5.72M
MRK icon
43
Merck
MRK
$328B
– –
-62,880
Closed -$4.98M
SEM
44
DELISTED
Select Medical
SEM
– –
-194,880
Closed -$2.19M
NUVA
45
DELISTED
NuVasive, Inc.
NUVA
– –
-45,100
Closed -$2.19M
LHCG
46
DELISTED
LHC Group LLC
LHCG
– –
-17,500
Closed -$3.72M
PPD
47
DELISTED
PPD, Inc. Common Stock
PPD
– –
-200,000
Closed -$7.4M
1
2

Similar funds

AFP
ATX Financial Planning Austin, Texas $132M AUM
PCGDR
Pangea Capital Gestao de Recursos Rio De Janeiro $131M AUM
ACM
Alcosta Capital Management San Ramon, California $131M AUM 34.7% 1-Year Est. Return
9C
9823 Capital Dallas, Texas $132M AUM
STFP
Signal Tree Financial Partners Copley, Ohio $132M AUM 15.43% 1-Year Est. Return
ADEF
ABS Direct Equity Fund Stamford, Connecticut $131M AUM 7.53% 1-Year Est. Return
AC
Aldebaran Capital Carmel, Indiana $131M AUM 34.7% 1-Year Est. Return
CIP
Castlefield Investment Partners Manchester $131M AUM

Sivik Global Healthcare's Q4 2020 Portfolio in Review

As of Q4 2020, Sivik Global Healthcare held 47 positions worth $245M, up 5.5% from $232M the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Sivik Global Healthcare withdrew a net $9.76M in Q4 2020, closing 9 positions and reducing 14 holdings. Its most notable exit was PPD, Inc. Common Stock, an estimated $7.4M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, up from 98% a quarter earlier, followed by Energy.

Against the trend, Sivik Global Healthcare opened a new position in Elevance Health worth $6.42M.

  • Sivik Global Healthcare's largest Q4 2020 buy was Elevance Health: 20,000 shares worth $6.42M.
  • Sivik Global Healthcare added most to Regeneron Pharmaceuticals in Q4 2020, an estimated $5.4M increase.
  • Sivik Global Healthcare's biggest Q4 2020 reduction was CATALENT, INC., cutting an estimated $3.63M.
  • Sivik Global Healthcare fully exited PPD, Inc. Common Stock in Q4 2020, selling an estimated $7.4M.
  • Sivik Global Healthcare's ten largest holdings make up 38% of its $245M portfolio in Q4 2020.
  • Sivik Global Healthcare opened 9 new positions and closed 9 in Q4 2020.
  • Sivik Global Healthcare's portfolio value rose 5.5% quarter-over-quarter to $245M.

Based on Sivik Global Healthcare's 13F filing for Q4 2020, filed 16 Feb 2021.